Document Detail

Review article: understanding adherence to medication in ulcerative colitis - innovative thinking and evolving concepts.
MedLine Citation:
PMID:  20815833     Owner:  NLM     Status:  In-Process    
BACKGROUND: Non-adherence to medication is an important challenge in the treatment of ulcerative colitis (UC). Epidemiological studies have demonstrated that non-adherence affects 40-60% of UC patients, and has a substantial impact on the course of the disease. In one study, non-adherence was associated with a five-fold increase in the risk of relapse.
AIM: We review factors contributing to non-adherence to UC therapy, and emerging concepts in addressing the problem.
METHODS: A search of the published literature on adherence to medication, combined with the authors' knowledge of the field.
RESULTS: Adherence is a complex, multifactorial issue, with factors varying between patients and changing over time. Identifying patients at risk of non-adherence is a key first step in targeting interventions to improve adherence. However, investigations of single factors that affect adherence have provided conflicting evidence. Evaluating physical and perceptual barriers to adherence, and acknowledging the role of patients' beliefs and concerns regarding treatment provide valuable insights into the causes of non-adherence. This allows development of targeted interventions to improve adherence to UC therapy. Clinical tools to identify patients at risk of non-adherence are being developed to facilitate this approach.
CONCLUSIONS: To help patients adhere better to maintenance therapy for UC, it is vital to consider patients' beliefs and concerns, and to evaluate and address both physical and perceptual barriers to adherence.
S V Kane; A Robinson
Related Documents :
15589473 - Center experience in liver transplantation (ltx): management of dermal side effects cau...
15462253 - Pharmacist-facilitated enrollment in medication assistance programs in a private ambula...
19373113 - Transient monoparesis after blade plate removal in a hutchinson-gilford progeria syndro...
Publication Detail:
Type:  Journal Article; Review     Date:  2010-09-03
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  32     ISSN:  1365-2036     ISO Abbreviation:  Aliment. Pharmacol. Ther.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  1051-8     Citation Subset:  IM    
Copyright Information:
© 2010 Blackwell Publishing Ltd.
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network.
Next Document:  Minimising harm to older Victorians from heatwaves: A qualitative study of the role of community-bas...